Jason M. Singer

Emergency Medicine
12255 Fair Lakes Pkwy
Fairfax, VA 22033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice.

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and glycerol-mediated gluconeogenesis in mice.

Journal: bioRxiv : the preprint server for biology
Published: February 24, 2023

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice.

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice.

Journal: iScience
Published: February 17, 2023

Adipocyte lipin 1 expression associates with human metabolic health and regulates systemic metabolism in mice.

Adipocyte lipin 1 expression associates with human metabolic health and regulates systemic metabolism in mice.

Journal: The Journal of clinical investigation
Published: February 14, 2023

Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice.

Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice.

Journal: bioRxiv : the preprint server for biology
Published: February 13, 2023

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.

Journal: Cell reports
Published: November 17, 2022

Monoacylglycerol O-acyltransferase 1 lowers adipocyte differentiation capacity in vitro but does not affect adiposity in mice.

Monoacylglycerol O-acyltransferase 1 lowers adipocyte differentiation capacity in vitro but does not affect adiposity in mice.

Journal: Obesity (Silver Spring, Md.)
Published: February 16, 2022

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.

Journal: Cell reports
Published: September 16, 2021

Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.

Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.

Journal: Molecular metabolism
Published: January 26, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026